ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

PEPG PepGen Inc

11.17
-0.675 (-5.70%)
最終更新日: 02:18:20
15分遅延
名称 銘柄コード 市場 種別
PepGen Inc PEPG NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.675 -5.70% 11.17 02:18:20
始値 安値 高値 終値 前日終値
11.74 11.165 12.25 11.845
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/1405:05GLOBEPepGen to Participate in Upcoming Investor Conferences
2024/3/1320:00GLOBEPepGen Receives U.S. FDA Orphan Drug and Rare Pediatric..
2024/3/0706:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0706:01GLOBEPepGen Reports Fourth Quarter and Full Year 2023 Financial..
2024/3/0706:00EDGAR2Form 8-K - Current report
2024/3/0421:27EDGAR2Form 8-K - Current report
2024/3/0421:00GLOBEPepGen Announces Clearance of CTA by UK Medicines &..
2024/3/0207:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0207:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0207:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2022:00EDGAR2Form 8-K - Current report
2024/2/2022:00GLOBEPepGen Receives U.S. FDA Fast Track Designation for..
2024/2/0806:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/0721:36EDGAR2Form 8-K - Current report
2024/2/0721:30GLOBEPepGen Announces Pricing of $80.1 Million Underwritten..
2024/1/1722:00EDGAR2Form 8-K - Current report
2024/1/1721:00GLOBEMary Beth DeLena Joins PepGen as General Counsel and..
2024/1/0821:00EDGAR2Form 8-K - Current report
2024/1/0821:00GLOBEPepGen Announces First Patient Dosed in CONNECT1-EDO51 Phase..
2023/12/1822:00EDGAR2Form 8-K - Current report
2023/12/1822:00GLOBEPepGen Announces First Patient Dosed in Phase 1 FREEDOM-DM1..
2023/11/1522:00EDGAR2Form 8-K - Current report
2023/11/1522:00GLOBEPepGen Announces Appointment of Howard Mayer, M.D. to Board..
2023/11/0822:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0822:00EDGAR2Form 8-K - Current report
2023/11/0822:00GLOBEPepGen Reports Third Quarter 2023 Financial Results and..
2023/10/1220:52DJNFDA Lifts Hold on PepGen's New Drug Application for..
2023/10/1220:05EDGAR2Form 8-K - Current report
2023/10/1220:00GLOBEPepGen Inc. Announces FDA has Lifted the Clinical Hold on..
2023/9/2805:16GLOBEPepGen Announces Upcoming Presentations at the 28th Annual..
2023/9/0705:06EDGAR2Form 8-K - Current report
2023/9/0705:05GLOBEPepGen Inc. Announces Clearance of CTA by Health Canada to..
2023/9/0621:16EDGAR2Form 8-K - Current report
2023/9/0621:00GLOBEPepGen Inc. Presents PGN-EDODM1 Preclinical Data Supporting..
2023/9/0121:00GLOBEPepGen Announces Presentations at the 2023 Myotonic..
2023/8/0821:49EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/8/0821:27EDGAR2Form 8-K - Current report
2023/8/0821:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0821:15EDGAR2Form 8-K - Current report
2023/8/0821:15GLOBEPepGen Reports Second Quarter 2023 Financial Results and..
2023/6/1406:07DJNPepGen Withdraws Guidance on Launch of Study for Muscle..
2023/6/1405:05GLOBEPepGen Inc. Provides Update on Planned Initiation of Phase 1..
2023/5/3106:24DJNPepGen Shares Tumble 18.4% After FDA Issues Hold Notice on..
2023/5/3105:05GLOBEPepGen Inc. Announces Clinical Hold in the U.S. on IND..
2023/5/1820:00GLOBEPepGen Announces Clearance by Health Canada of CTA for..
2023/5/1120:00GLOBEPepGen Reports First Quarter 2023 Financial Results and..
2023/5/0421:00GLOBEPepGen to Participate in the Bank of America Securities 2023..

最近閲覧した銘柄

Delayed Upgrade Clock